Guangdong VTR Bio-Tech Co., Ltd. Stock price

Equities

300381

CNE100001RJ8

Fishing & Farming

End-of-day quote Shenzhen S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
5.51 CNY +2.99% Intraday chart for Guangdong VTR Bio-Tech Co., Ltd. -3.50% -25.24%
Sales 2021 1.89B 262M Sales 2022 1.17B 162M Capitalization 3.69B 510M
Net income 2021 -119M -16.47M Net income 2022 18M 2.49M EV / Sales 2021 3.38 x
Net Debt 2021 571M 79M Net cash position 2022 1.41B 195M EV / Sales 2022 1.94 x
P/E ratio 2021
-48.9 x
P/E ratio 2022
205 x
Employees 1,148
Yield 2021
0.84%
Yield 2022
1.31%
Free-Float 55.92%
More Fundamentals * Assessed data
Dynamic Chart
Guangdong VTR Bio-Tech Co., Ltd. completed the acquisition of 30% stake in Hunan Micolta Bioresource Inc. from Phytobiotics Futterzusatzstoffe GmbH. CI
Guangdong VTR Bio-Tech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Guangdong VTR Bio-Tech Co., Ltd. agreed to acquire 30% stake in Hunan Micolta Bioresource Inc. from Phytobiotics Futterzusatzstoffe GmbH for CNY 80 million. CI
Guangdong VTR Bio-Tech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Guangdong VTR Bio-Tech Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 06 July 2023 CI
Guangdong VTR Bio-Tech Sets Up New Subsidiary MT
Guangdong VTR Bio-Tech Co., Ltd. Approves Cash Dividend for 2022 CI
Tranche Update on Guangdong VTR Bio-Tech Co., Ltd.'s Equity Buyback Plan announced on May 18, 2022. CI
Guangdong VTR Bio-Tech Co., Ltd.'s Equity Buyback announced on May 18, 2022 has closed with 10,887,600 shares, representing 2.22% for CNY 100.11 million. CI
Guangdong VTR Bio-Tech Co., Ltd. Proposes Final Cash Dividend for the Year 2022 CI
Guangdong VTR Bio-Tech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Tranche Update on Guangdong VTR Bio-Tech Co., Ltd.'s Equity Buyback Plan announced on May 18, 2022. CI
Tranche Update on Guangdong VTR Bio-Tech Co., Ltd.'s Equity Buyback Plan announced on May 18, 2022. CI
Guangdong VTR Bio-Tech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Tranche Update on Guangdong VTR Bio-Tech Co., Ltd.'s Equity Buyback Plan announced on May 18, 2022. CI
More news
1 day+2.99%
1 week-3.50%
Current month+9.11%
1 month+1.47%
3 months-24.21%
6 months-26.04%
Current year-25.24%
More quotes
1 week
5.24
Extreme 5.24
5.76
1 month
4.85
Extreme 4.85
5.80
Current year
3.53
Extreme 3.53
7.52
1 year
3.53
Extreme 3.53
9.29
3 years
3.53
Extreme 3.53
12.38
5 years
3.53
Extreme 3.53
17.60
10 years
3.53
Extreme 3.53
37.28
More quotes
Managers TitleAgeSince
Director of Finance/CFO 60 01-12-31
Chairman 52 96-07-31
Chairman 62 91-07-31
Members of the board TitleAgeSince
Chairman 62 91-07-31
Director/Board Member 60 21-02-21
Chairman 52 96-07-31
More insiders
Date Price Change Volume
24-03-28 5.51 +2.99% 7,628,111
24-03-27 5.35 -0.93% 5,677,700
24-03-26 5.4 -0.55% 5,318,100
24-03-25 5.43 -2.86% 4,270,650
24-03-22 5.59 -2.78% 5,711,736

End-of-day quote Shenzhen S.E., March 27, 2024

More quotes
GUANGDONG VTR BIO -TECH CO., LTD is a feed enzyme preparations and bio-energy enzyme preparations producer. The Company principally engages in the manufacture and distribution of feedstuff additives, additive pre-mixed feedstuffs, veterinary powders and granules. The Company's products include enzyme preparations for feedstuffs, including composite enzyme for feedstuffs, phytase for feedstuffs and xylanase for feedstuffs, among others; bio-energy enzyme preparations; spinning enzyme products; food enzyme products; paper making enzyme products; other feedstuff additives, including antioxidants, acidifiers, attractants and fructo oligo saccharides feedstuff additives, as well as veterinary Chinese medicines.
More about the company
  1. Stock
  2. Equities
  3. Stock Guangdong VTR Bio-Tech Co., Ltd. - Shenzhen S.E.